Beximco Pharmaceuticals Limited

DSE-BXPHARMA
Dhaka Stock Exchange
Pharmaceutical Preparations
Global Rank
#17343
Country Rank
#16
Market Cap
315 M
Price
0.706
Change (%)
0.46%
Volume
147,544

Beximco Pharmaceuticals Limited (DSE-BXPHARMA) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
11/26/2020 1.1:1 x1.1 x5.850256 Forward
05/24/2015 1.05:1 x1.05 x5.318414 Forward
05/19/2014 1.05:1 x1.05 x5.065156 Forward
05/21/2013 1.15:1 x1.15 x4.823959 Forward
05/22/2012 1.21:1 x1.21 x4.194747 Forward
05/12/2011 1.2:1 x1.2 x3.466733 Forward
05/20/2010 1.15:1 x1.15 x2.888944 Forward
05/26/2009 1.2:1 x1.2 x2.512125 Forward
07/03/2008 1.1:1 x1.1 x2.093438 Forward
05/18/2005 1.25:1 x1.25 x1.903125 Forward
06/02/2003 1.015:1 x1.015 x1.5225 Forward
11/10/1997 1.5:1 x1.5 x1.5 Forward

Frequently Asked Questions

  • How much would Beximco Pharmaceuticals Limited stock be worth if it never split?
    If Beximco Pharmaceuticals Limited (stock symbol: DSE-BXPHARMA) had never undergone any stock splits, its price per share today would be approximately 4.13 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1.1-for-1) that occurred on 11/26/2020.
  • Beximco Pharmaceuticals Limited (stock symbol: DSE-BXPHARMA) has undergone a total of twelve stock splits. The most recent split occurred on 11/26/2020. One share bought prior to the first split on 11/10/1997 would now equal 5.85 shares.
  • Beximco Pharmaceuticals Limited (stock symbol: DSE-BXPHARMA) has undergone twelve stock splits in its history. The most recent split, a 1.5-for-1 split, occurred on 11/26/2020. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.